Mono Pharmacare Complete Financial Statements
In FYNone, Mono Pharmacare (MONOPHARMA) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00. Full financial statements from FY2023 to FY2026 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Mono Pharmacare stock price NSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
MONOPHARMA Revenue, Net Profit & EBITDA — Year-on-Year Growth
MONOPHARMA YoY (March 2026 vs Period) — revenue -100.0%, EBITDA -100.0%, expenses -100.0%. Check MONOPHARMA market cap trends to track the company's total market size over time.
MONOPHARMA Income Statement — Revenue, EBITDA & Net Profit
Mono Pharmacare revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None). View MONOPHARMA 52-week performance for the annual high/low range and current price position.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 166 | 169 | 122 | 33 |
| Expenses | 0 | 162 | 161 | 116 | 31 |
| EBITDA | 0 | 4 | 9 | 6 | 2 |
| Operating Profit Margin % | 0.00% | 2.00% | 5.00% | 5.00% | 7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 3 | 4 | 3 | 1 |
| Profit Before Tax | 0 | 1 | 5 | 3 | 1 |
| Tax | 0 | 0 | 1 | 1 | 0 |
| Net Profit | 0 | 0 | 3 | 3 | 1 |
| Earnings Per Share (₹) | 0.00 | 0.20 | 1.75 | 1.58 | 0.79 |
MONOPHARMA Balance Sheet — Assets, Liabilities & Shareholders' Equity
MONOPHARMA total assets ₹122 Cr, total equity ₹32 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 122 | 110 | 81 | 63 |
| Current Assets | 121 | 109 | 80 | 61 |
| Fixed Assets | 1 | 1 | 1 | 1 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 42 | 0 | 0 | 0 |
| Other Assets | 0 | 109 | 80 | 62 |
| LIABILITIES | ||||
| Total Liabilities | ||||
| Current Liabilities | 27 | 26 | 17 | 15 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 32 | 31 | 28 | 14 |
| Share Capital | 18 | 18 | 18 | 12 |
| Reserves & Surplus | 14 | 14 | 10 | 1 |
MONOPHARMA Cash Flow Statement — Operating, Investing & Financing
Mono Pharmacare operating cash flow ₹-4 Cr, investing ₹0 Cr, financing ₹5 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | -4 | -9 | -40 |
| Investing Activities | 0 | 0 | -1 |
| Financing Activities | 5 | 8 | 41 |
| Net Cash Flow | 0 | 0 | 0 |